BrainsWay (BWAY) vs Neuropace (NPCE)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
BrainsWay (BWAY) has outperformed Neuropace (NPCE) over the past year, gaining 52.6% versus a gain of 19.8%. Over five years, BWAY leads with a +197.6% price change compared with -18.6% for NPCE. BrainsWay is the larger company by market cap ($467.7 million vs $438.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BWAY | NPCE |
|---|---|---|
| Share price | $11.62 | $12.76 |
| Market cap | $467.74M | $437.98M |
| 1-day change | -2.27% | +0.71% |
| YTD return | +22.19% | -17.36% |
| 1-year return | +52.59% | +19.81% |
| 5-year return | +197.57% | -18.57% |
| P/E ratio (TTM) | 50.52 | — |
| Forward P/E | 22.93 | — |
| EPS (TTM) | $0.23 | $-0.57 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $17.40 | $19.60 |
| 52-week low | $7.14 | $9.22 |
| Distance from 52-week high | -33.22% | -34.90% |
| Analyst consensus | none | none |
| Avg. price target upside | +65.83% | +56.74% |
| Average volume | 119.50K | 170.54K |
| Shares outstanding | 40.25M | 34.32M |
| Employees | 129 | 220 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BWAY has outperformed NPCE by 32.8 percentage points over the past year.
About BrainsWay
BWAY stock →BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally.
Healthcare · Medical Devices · 129 employees
About Neuropace
NPCE stock →NeuroPace, Inc. operates as a medical device company in the United States.
Healthcare · Medical Devices · 220 employees
BWAY vs NPCE FAQ
Which is bigger, BrainsWay or Neuropace?
BrainsWay (BWAY) is larger, with a market capitalization of $467.74M compared with $437.98M for Neuropace (NPCE).
Which stock has performed better over the past year, BWAY or NPCE?
BWAY returned +52.59% over the past 12 months, compared with +19.81% for NPCE (price return, excluding dividends). Past performance does not predict future results.
Are BrainsWay and Neuropace in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.